Understanding the menopausal transition, and managing its clinical challenges

Sexuality, Reproduction and Menopause

Volumn 3, Issue 1, 2005, Pages 12-17

  Arroyo, Armando ^a   Yeh, John ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALPHA TOCOPHEROL; ANDROGEN; CALCIUM; CIMICIFUGA RACEMOSA EXTRACT; CLONIDINE; ESTROGEN; ESTRONE SULFATE; FOLLITROPIN; GLUCOCORTICOID; GONADORELIN; GONADOTROPIN; IBUPROFEN; INHIBIN A; INHIBIN B; LEVONORGESTREL; LUTEINIZING HORMONE; MEDROXYPROGESTERONE; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PROSTAGLANDIN E2; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE; VITAMIN D;

AGING; ANDROGEN BLOOD LEVEL; ANOVULATION; BONE DENSITY; CALCIUM INTAKE; CLIMACTERIUM; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG CHOICE; DRUG EFFICACY; ENDOMETRIUM BIOPSY; ESTROGEN BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; HORMONAL THERAPY; HOT FLUSH; HUMAN; LOW DRUG DOSE; LUTEINIZING HORMONE BLOOD LEVEL; MENARCHE; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; OVARY FOLLICLE ATRESIA; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX HORMONE DETERMINATION; SIDE EFFECT; SLEEP DISORDER; TESTOSTERONE BLOOD LEVEL; UTERUS BLEEDING;

EID: 20844452776     PISSN: 15462501     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1546-2501(05)00002-2     Document Type: Review

References (22)

1. MR Soules S Sherman E Parrott et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW) Fertil Steril 76 2001 874-878
2. SM McKinlay DJ Brambilla JG Posner The normal menopause transition Maturitas 14 1992 103-115
3. MJ Faddy RG Gosden A Gougeon et al. Accelerated disappearance of ovarian follicles in mid-life: Implications for forecasting menopause Hum Reprod 7 1992 1342-1346
4. G Zapantis N Santoro The menopausal transition: Characteristics and management Best Pract Res Clin Endocrinol Metab 17 2003 33-52
5. NA Klein PJ Illingworth NP Groome Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: A study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles J Clin Endocrinol Metab 81 1996 2742-2745
6. CK Welt DJ McNicholl AE Taylor JE Hall Female reproductive aging is marked by decreased secretion of dimeric inhibin J Clin Endo crinol Metab 84 1999 105-111
7. N Santoro JR Brown T Adel JH Skurnick Characterization of reproductive hormonal dynamics in the perimenopause J Clin Endocrinol Metab 81 1996 1495-1501
8. G Zapantis N Santoro Ovarian ageing and the menopausal transition Best Pract Res Clin Obstet Gynaecol 16 2002 263-276
9. G Rannevik S Jeppsson O Johnell et al. A longitudinal study of the perimenopausal transition: Altered profiles of steroid and pituitary hormones, SHBG and bone mineral density Maturitas 21 1995 103-113
10. HG Burger EC Dudley JL Hopper et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women J Clin Endocrinol Metab 84 1999 4025-4030
11. HG Burger EC Dudley J Cui et al. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition J Clin Endocrinol Metab 85 2000 2832-2838
12. RT Scott MS Opsahl MR Leonardi et al.Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age Hum Reprod 10 1995 1706-1710
13. RT Scott D Navot Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization Fertil Steril 61 1994 880-885
14. MA Akman HF Erden SB Tosun et al. Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: Results of a prospective randomized trial Hum Reprod 16 2001 868-870
15. AE Treloar RE Boynton BG Behn BW Brown Variation of the human menstrual cycle through reproductive life Int J Fertil 12 1967 77-126
16. MH Kim Dysfunctional uterine bleeding LJ Copeland Textbook of Gynecology 2000 WB Saunders Co Philadelphia 539
17. RR Freedman Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes Fertil Steril 70 1998 332-337
18. PG McDonough The randomized world is not without its imperfections: reflections on the Women's Health Initiative Study Fertil Steril 78 2002 951-956
19. D Brewer J Nashelsky LB Hansen What nonhormonal therapies are effective for postmenopausal vasomotor symptoms? J Fam Pract 52 2003 324-325
20. V Stearns KL Beebe M Ivengar E Dube Paroxetine controlled release in the treatment of menopausal hot flashes. A randomized controlled study JAMA 289 2003 2827-2834
21. P Amato DM Marcus Review of alternative therapies for treatment of menopausal symptoms Climacteric 6 2003 278-284
22. ML Gourlay SA Brown Clinical considerations in premenopausal osteoporosis Arch Intern Med 164 2004 603-614